2.要約中間連結財務諸表及び主な注記
(1)要約中間連結財政状態計算書
| | | (単位:千円) |
| 前連結会計年度 (2024年12月31日) | | 当中間連結会計期間 (2025年6月30日) |
資産 | | | |
非流動資産 | | | |
有形固定資産 | 5,696,491 | | 5,202,097 |
使用権資産 | 1,559,345 | | 1,527,049 |
のれん | 15,994,981 | | 14,666,004 |
無形資産 | 11,026,585 | | 11,268,661 |
持分法で会計処理されている投資 | 386,978 | | 360,559 |
繰延税金資産 | 2,234,803 | | 2,129,756 |
その他の金融資産 | 5,764,350 | | 5,075,942 |
その他の非流動資産 | 56,730 | | 69,964 |
非流動資産合計 | 42,720,266 | | 40,300,037 |
| | | |
流動資産 | | | |
棚卸資産 | 2,529,642 | | 3,383,760 |
営業債権及びその他の債権 | 6,236,284 | | 5,673,462 |
その他の金融資産 | 9,291,037 | | 7,078,558 |
その他の流動資産 | 1,050,642 | | 761,439 |
現金及び現金同等物 | 10,115,037 | | 10,524,916 |
流動資産合計 | 29,222,643 | | 27,422,138 |
資産合計 | 71,942,909 | | 67,722,176 |
| | | |
負債及び資本 | | | |
非流動負債 | | | |
借入金 | 1,200,000 | | 1,000,000 |
リース負債 | 735,590 | | 735,337 |
繰延税金負債 | 2,171,430 | | 2,047,733 |
その他の金融負債 | 15,454,160 | | 14,832,646 |
その他の非流動負債 | 203,422 | | 388,159 |
非流動負債合計 | 19,764,605 | | 19,003,877 |
| | | |
流動負債 | | | |
営業債務及びその他の債務 | 2,263,911 | | 1,950,446 |
借入金 | 4,575,000 | | 2,400,000 |
1年内返済予定の長期借入金 | 400,000 | | 400,000 |
リース負債 | 295,289 | | 326,734 |
未払法人所得税 | 2,611,203 | | 2,710,737 |
その他の金融負債 | 888 | | 4,495 |
その他の流動負債 | 2,318,111 | | 2,612,282 |
流動負債合計 | 12,464,403 | | 10,404,696 |
負債合計 | 32,229,009 | | 29,408,573 |
| | | |
資本 | | | |
資本金 | 13,276,700 | | 13,463,507 |
資本剰余金 | 6,626,254 | | 8,874,885 |
自己株式 | △15,372 | | △15,629 |
利益剰余金 | 9,888,797 | | 8,973,417 |
その他の資本の構成要素 | 6,669,736 | | 3,973,112 |
親会社の所有者に帰属する持分合計 | 36,446,115 | | 35,269,293 |
非支配持分 | 3,267,785 | | 3,044,309 |
資本合計 | 39,713,900 | | 38,313,602 |
資本及び負債の合計 | 71,942,909 | | 67,722,176 |
E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2025-01-012025-06-30Q22025-12-312024-01-012024-06-302024-12-311falsefalsefalse216002023-12-31216002024-12-31216002024-01-012024-06-30216002024-06-30216002025-01-012025-06-30216002025-06-30216002025-08-14216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-12-31jpigp_cor:ShareCapitalIFRSMember216002024-12-31jpigp_cor:CapitalSurplusIFRSMember216002024-12-31jpigp_cor:TreasurySharesIFRSMember216002024-12-31jpigp_cor:RetainedEarningsIFRSMember216002024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002025-01-012025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-01-012025-06-30jpigp_cor:ShareCapitalIFRSMember216002025-01-012025-06-30jpigp_cor:CapitalSurplusIFRSMember216002025-01-012025-06-30jpigp_cor:TreasurySharesIFRSMember216002025-01-012025-06-30jpigp_cor:RetainedEarningsIFRSMember216002025-01-012025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-01-012025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-01-012025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-01-012025-06-30jpigp_cor:NonControllingInterestsIFRSMember216002025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-06-30jpigp_cor:ShareCapitalIFRSMember216002025-06-30jpigp_cor:CapitalSurplusIFRSMember216002025-06-30jpigp_cor:TreasurySharesIFRSMember216002025-06-30jpigp_cor:RetainedEarningsIFRSMember216002025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpcrp_cor:ReportableSegmentsMember216002024-01-012024-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002025-01-012025-06-30jpcrp_cor:ReportableSegmentsMember216002025-01-012025-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002025-01-012025-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMemberiso4217:JPYxbrli:pureiso4217:JPYxbrli:shares